Long-term Efficacy of Vedolizumab for Ulcerative Colitis

V. Loftus, Edward; Colombel, Jean‐Frédéric; G. Feagan, Brian; Vermeire, Séverine; J. Sandborn, William; E. Sands, Bruce; Danese, Silvio; D’Haens, Geert; Kaser, Arthur; Panaccione, Remo; T. Rubin, David; Shafran, Ira; McAuliffe, Megan; Kaviya, Arpeat; Sankoh, Serap; Mody, Reema; Abhyankar, Brihad; Smyth, Michael

doi:10.1093/ecco-jcc/jjw177

Public

Long-term Efficacy of Vedolizumab for Ulcerative Colitis

Published in Journal of Crohn s and Colitis • Sep 28, 2016

Authors:

Edward V. Loftus

Jean‐Frédéric Colombel

Brian G. Feagan

Abstract

BACKGROUND AND AIMS: The GEMINI long-term safety [LTS] study is a continuing phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin antagonist for ulcerative colitis [UC] and Crohn's disease. We provide an interim analysis of efficacy in patients with UC. METHODS: Patie...

Subject

Vedolizumab

Medicine

Ulcerative colitis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!